Calgary

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)4 trials

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• LEO Pharma5 trials

Running trials

• Recruiting

  A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

  NCT07013201· Phase 2· LEO Pharma· Source

  Contact: Clinical Disclosure

Closed trials

• Recruiting

  A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  NCT06311682· Phase 3· LEO Pharma· Source

  Contact: Clinical Disclosure

• Completed

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· Phase 3· LEO Pharma· Source

• Completed

  A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

  NCT05259722· Phase 3· LEO Pharma· Source

• Completed

  Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

  NCT03587805· Phase 3· LEO Pharma· Source